Gravestock MB - Search Results

1

The synthesis and antibacterial activity of totarol derivatives. Part 1: modifications of ring-C and pro-drugs.

Evans GB, Furneaux RH, Gravestock MB, Lynch GP, Scott GK. Evans GB, et al. Among authors: gravestock mb. Bioorg Med Chem. 1999 Sep;7(9):1953-64. doi: 10.1016/s0968-0896(99)00162-5. Bioorg Med Chem. 1999. PMID: 10530944

2

Novel substituted (pyridin-3-yl)phenyloxazolidinones: antibacterial agents with reduced activity against monoamine oxidase A and increased solubility.

Reck F, Zhou F, Eyermann CJ, Kern G, Carcanague D, Ioannidis G, Illingworth R, Poon G, Gravestock MB. Reck F, et al. Among authors: gravestock mb. J Med Chem. 2007 Oct 4;50(20):4868-81. doi: 10.1021/jm070428+. Epub 2007 Aug 28. J Med Chem. 2007. PMID: 17722903

3

New classes of antibacterial oxazolidinones with C-5, methylene O-linked heterocyclic side chains.

Gravestock MB, Acton DG, Betts MJ, Dennis M, Hatter G, McGregor A, Swain ML, Wilson RG, Woods L, Wookey A. Gravestock MB, et al. Bioorg Med Chem Lett. 2003 Dec 1;13(23):4179-86. doi: 10.1016/j.bmcl.2003.07.033. Bioorg Med Chem Lett. 2003. PMID: 14622997

4

Identification of 4-substituted 1,2,3-triazoles as novel oxazolidinone antibacterial agents with reduced activity against monoamine oxidase A.

Reck F, Zhou F, Girardot M, Kern G, Eyermann CJ, Hales NJ, Ramsay RR, Gravestock MB. Reck F, et al. Among authors: gravestock mb. J Med Chem. 2005 Jan 27;48(2):499-506. doi: 10.1021/jm0400810. J Med Chem. 2005. PMID: 15658863

5

New carbon-linked azole oxazolidinones with improved potency and pharmacokinetics.

Hauck SI, Cederberg C, Doucette A, Grosser L, Hales NJ, Poon G, Gravestock MB. Hauck SI, et al. Among authors: gravestock mb. Bioorg Med Chem Lett. 2007 Jan 15;17(2):337-40. doi: 10.1016/j.bmcl.2006.10.063. Epub 2006 Oct 26. Bioorg Med Chem Lett. 2007. PMID: 17095223

6

Monoamine oxidases: to inhibit or not to inhibit.

Ramsay RR, Gravestock MB. Ramsay RR, et al. Among authors: gravestock mb. Mini Rev Med Chem. 2003 Mar;3(2):129-36. doi: 10.2174/1389557033405287. Mini Rev Med Chem. 2003. PMID: 12570845 Review.

7

Orientation of oxazolidinones in the active site of monoamine oxidase.

Jones TZ, Fleming P, Eyermann CJ, Gravestock MB, Ramsay RR. Jones TZ, et al. Among authors: gravestock mb. Biochem Pharmacol. 2005 Aug 1;70(3):407-16. doi: 10.1016/j.bcp.2005.05.001. Biochem Pharmacol. 2005. PMID: 15950194

8

Recent developments in the discovery of novel oxazolidinone antibacterials.

Gravestock MB. Gravestock MB. Curr Opin Drug Discov Devel. 2005 Jul;8(4):469-77. Curr Opin Drug Discov Devel. 2005. PMID: 16022183 Review.

9

Experimental approaches to antifungal chemotherapy.

Ryley JF, Wilson RG, Gravestock MB, Poyser JP. Ryley JF, et al. Among authors: gravestock mb. Adv Pharmacol Chemother. 1981;18:49-176. doi: 10.1016/s1054-3589(08)60254-9. Adv Pharmacol Chemother. 1981. PMID: 7034505 Review. No abstract available.

10

Synthesis and structure-activity relationships of a novel antifungal agent, ICI 195,739.

Boyle FT, Gilman DJ, Gravestock MB, Wardleworth JM. Boyle FT, et al. Among authors: gravestock mb. Ann N Y Acad Sci. 1988;544:86-100. doi: 10.1111/j.1749-6632.1988.tb40391.x. Ann N Y Acad Sci. 1988. PMID: 3063188

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters